Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Versatile delivery systems for non-platinum metal-based anticancer therapeutic agents
Yi Gou, Guojin Huang, Jinlong Li, et al.
Coordination Chemistry Reviews (2021) Vol. 441, pp. 213975-213975
Closed Access | Times Cited: 53

Showing 1-25 of 53 citing articles:

Reversal of cisplatin chemotherapy resistance by glutathione-resistant copper-based nanomedicineviacuproptosis
Yao Lu, Qingqing Pan, Wenxia Gao, et al.
Journal of Materials Chemistry B (2022) Vol. 10, Iss. 33, pp. 6296-6306
Closed Access | Times Cited: 111
Developing a Copper(II) Agent Based on His-146 and His-242 Residues of Human Serum Albumin Nanoparticles: Integration To Overcome Cisplatin Resistance and Inhibit the Metastasis of Nonsmall Cell Lung Cancer
Ming Jiang, Zhenlei Zhang, Wenjuan Li, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 13, pp. 9447-9458
Closed Access | Times Cited: 44
Developing a Multitargeted Anticancer Palladium(II) Agent Based on the His-242 Residue in the IIA Subdomain of Human Serum Albumin
Wenjuan Li, Shanhe Li, Zhenlei Zhang, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8564-8579
Closed Access | Times Cited: 33
Developing a Gadolinium(III) Compound Based on Apoferritin for Targeted Magnetic Resonance Imaging and Dual-Modal Therapy of Cancer
Xueyu Man, Tongfu Yang, Wenjuan Li, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 11, pp. 7268-7279
Closed Access | Times Cited: 24
Developing a Ruthenium(III) Complex to Trigger Gasdermin E-Mediated Pyroptosis and an Immune Response Based on Decitabine and Liposomes: Targeting Inhibition of Gastric Tumor Growth and Metastasis
Wenjuan Li, Shanhe Li, Gang Xu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 18, pp. 13072-13085
Closed Access | Times Cited: 22
Development of Cu(II) 4-hydroxybenzoylhydrazone complexes that induce mitochondrial DNA damage and mitochondria-mediated apoptosis in liver cancer
Ming Jiang, Qiwei Yan, Yuanping Fu, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112550-112550
Closed Access | Times Cited: 8
Co-delivery of anticancer drugs via poly(ionic crosslinked chitosan-palladium) nanocapsules: Targeting more effective and sustainable cancer therapy
Yasser A. Hassan, Mohammad Y. Alfaifi, Ali A. Shati, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 69, pp. 103151-103151
Closed Access | Times Cited: 34
Dithiocarbazate–FeIII, −CoIII, −NiII, and −ZnII Complexes: Design, Synthesis, Structure, and Anticancer Evaluation
Yi Gou, Xiaoying Jia, Li Hou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 9, pp. 6677-6689
Closed Access | Times Cited: 32
Developing a Gallium(III) Agent Based on the Properties of the Tumor Microenvironment and Lactoferrin: Achieving Two-Agent Co-delivery and Multi-targeted Combination Therapy of Cancer
Tongfu Yang, Zhenlei Zhang, Juzheng Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 793-803
Closed Access | Times Cited: 28
Assessment of Mononuclear/Dinuclear copper acylhydrazone complexes for lung cancer treatment
YouRu Wu, D. Christine Wu, Jianfeng Lan, et al.
Bioorganic Chemistry (2024) Vol. 144, pp. 107122-107122
Closed Access | Times Cited: 6
Developing a Novel Indium(III) Agent Based on Human Serum Albumin Nanoparticles: Integrating Bioimaging and Therapy
Zhenlei Zhang, Tongfu Yang, Juzheng Zhang, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 7, pp. 5392-5406
Closed Access | Times Cited: 25
Unlocking the potential of iridium and ruthenium arene complexes as anti-tumor and anti-metastasis chemotherapeutic agents
Mengdi Lv, Xiaoting Qian, Shijie Li, et al.
Journal of Inorganic Biochemistry (2022) Vol. 238, pp. 112057-112057
Closed Access | Times Cited: 23
Metal-Based Drugs in Cancer Therapy
Sourav Debnath, Abhijit Datta, Arijit Das, et al.
International Journal of experimental research and review (2024) Vol. 37, pp. 159-173
Open Access | Times Cited: 5
Synthesis, structural, equilibrium, anticancer, DNA binding, and computational investigation of binary and ternary palladium(II) complexes based on N-(2-hydroxyethyl)ethylenediamine
Mona S. Ragab, Mohamed M. Shoukry, Hanaa M. El-Madany, et al.
Journal of Coordination Chemistry (2025), pp. 1-22
Closed Access
Development a stannum(IV) 8-quinolinecarbaldehyde thiosemicarbazone complex with remarkable anticancer activity via pyroptosis and apoptosis
Xiaoling Wu, Jinhui Pang, Wenjuan Li, et al.
Journal of Molecular Structure (2025), pp. 142225-142225
Closed Access
Exploring Anticancer Activity and DNA Binding of Metal (II) Salicylaldehyde Schiff Base Complexes: A Convergence of Experimental and Computational Perspectives
Ibrahim Waziri, Sheldon Sookai, Tunde L. Yusuf, et al.
Applied Organometallic Chemistry (2025) Vol. 39, Iss. 5
Open Access
Study of the anticancer potential of Cd complexes of selenazoyl-hydrazones and their sulfur isosters
Sanja B. Marković, Natalia Maciejewska, Mateusz Olszewski, et al.
European Journal of Medicinal Chemistry (2022) Vol. 238, pp. 114449-114449
Closed Access | Times Cited: 19
Enzyme-Triggered Size-Switchable Nanosystem for Deep Tumor Penetration and Hydrogen Therapy
Yongju He, Xiangjie Tian, Xingyu Fan, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 1, pp. 552-565
Closed Access | Times Cited: 12
Anticancer Activity and Mode of Action of Cu(II), Zn(II), and Mn(II) Complexes with 5-Chloro-2-N-(2-quinolylmethylene)aminophenol
Shuangshuang Gai, Liqin He, Mingxian He, et al.
Molecules (2023) Vol. 28, Iss. 12, pp. 4876-4876
Open Access | Times Cited: 12
Developing a Hetero-Trinuclear Erbium(III)–Copper(II) Complex Based on Apoferritin: Targeted Photoacoustic Imaging and Multimodality Therapy of Tumor
Minghui Zhu, Xueyu Man, Yang Tongfu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 22, pp. 15424-15436
Closed Access | Times Cited: 11
The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs
Megan O’Shaughnessy, Orla Sheils, Anne‐Marie Baird
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12296-12296
Open Access | Times Cited: 9
Fluorescent and chromogenic organic probes to detect group 10 metal ions: design strategies and sensing applications
Nidhi Goswami, Sudhanshu Naithani, Jimmy Mangalam, et al.
Dalton Transactions (2023) Vol. 52, Iss. 41, pp. 14704-14732
Closed Access | Times Cited: 9
Mitochondria-targeted ruthenium complexes can be generated in vitro and in living cells to target triple-negative breast cancer cells by autophagy inhibition
Guandong Zhang, Mengmeng Wang, Yan Su, et al.
Journal of Inorganic Biochemistry (2024) Vol. 256, pp. 112574-112574
Closed Access | Times Cited: 3
Recent progress in stimuli‐activable metallo‐prodrugs for cancer therapy
Jinzhe Liang, Fangmian Wei, Hui Chao
Smart Molecules (2024)
Open Access | Times Cited: 3
Polymeric Nanosystems Applied for Metal-Based Drugs and Photosensitizers Delivery: The State of the Art and Recent Advancements
Kele Cristina Ferreira Dantas, Jânia dos Santos Rosário, Priscila P. Silva
Pharmaceutics (2022) Vol. 14, Iss. 7, pp. 1506-1506
Open Access | Times Cited: 14
Page 1 - Next Page

Scroll to top